Study to Assess the Efficacy and Safety of Dysport® in the Treatment of Chronic Plantar Fasciitis
Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
This study will investigate the hypothesis that the analgesic effect of a single injection of
Dysport (200 MU) induces a significant reduction of symptoms in chronic cases of plantar
fasciitis.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Ipsen
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA